Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

538
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
538
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.6K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.6K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

1.7K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.7K
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

465
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
465
Inflammation01:38

Inflammation

63.2K
Overview
63.2K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

786
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
786

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mitral Annular Function in Mitral Annular Calcification and Severe Mitral Regurgitation.

JACC. Advances·2025
Same author

Management of Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Replacement.

Journal of the Society for Cardiovascular Angiography & Interventions·2025
Same author

Clinical outcomes following TAVR for patients with low and very low gradient aortic stenosis.

Progress in cardiovascular diseases·2025
Same author

Multiomic analysis reveals a key BCAT1 role in mTOR activation by B cell receptor and TLR9.

The Journal of clinical investigation·2025
Same author

Outcomes of Transcatheter or Surgical Treatment of Severe Aortic Stenosis in Patients With Coronary Artery Disease.

Structural heart : the journal of the Heart Team·2025
Same author

Comparative 3-Year Outcomes of Transcatheter Aortic Valve Replacement in Failed Transcatheter Versus Surgical Valves.

The American journal of cardiology·2025

Related Experiment Video

Updated: Mar 7, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K

Lipid Lowering Therapy to Modify Plaque Microstructures.

Yu Kataoka1, Jordan Andrews, Rishi Puri

  • 1Department of Cardiovascular Medicine, National Cerebral & Cardiovascular Centre.

Journal of Atherosclerosis and Thrombosis
|February 28, 2017
PubMed
Summary
This summary is machine-generated.

Optical coherence tomography (OCT) reveals beneficial changes in atherosclerotic plaque microstructures with lower low-density lipoprotein cholesterol (LDL-C) levels. This imaging technique may help evaluate new therapies for cardiovascular disease.

More Related Videos

Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis
08:01

Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis

Published on: November 17, 2017

7.8K
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.8K

Related Experiment Videos

Last Updated: Mar 7, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K
Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis
08:01

Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis

Published on: November 17, 2017

7.8K
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.8K

Area of Science:

  • Cardiology
  • Medical Imaging
  • Biomedical Engineering

Background:

  • Atherosclerotic cardiovascular disease (ASCVD) poses a significant health burden, exacerbated by rising obesity and diabetes rates.
  • Lipid-lowering therapies, particularly targeting low-density lipoprotein cholesterol (LDL-C), are crucial for ASCVD prevention.
  • Intravascular imaging aids in understanding lipid-lowering effects on atherosclerotic plaques.

Purpose of the Study:

  • To investigate the role of Optical Coherence Tomography (OCT) in assessing atherosclerotic plaque changes.
  • To evaluate the impact of lipid-lowering therapies on plaque microstructures using OCT.
  • To explore the potential of OCT in guiding novel ASCVD therapeutic strategies.

Main Methods:

  • Utilizing Optical Coherence Tomography (OCT) for high-resolution intravascular imaging.
  • Analyzing plaque microstructural changes in response to lipid-lowering treatments.
  • Correlating OCT findings with lipid profiles, including LDL-C, triglycerides, and HDL-C.

Main Results:

  • OCT demonstrated favorable modifications in atherosclerotic plaque microstructures with reduced LDL-C levels.
  • Evidence suggests associations between other lipid targets (triglycerides, HDL-C) and plaque characteristics visualized by OCT.
  • OCT provides detailed insights into plaque morphology and instability.

Conclusions:

  • OCT is a valuable tool for visualizing and quantifying changes in atherosclerotic plaque microstructures.
  • OCT can assess the efficacy of lipid-lowering therapies on plaque stability.
  • OCT may play a key role in evaluating emerging treatments for ASCVD, especially in patients with residual risk.